技术. 视觉. 在线. 了解细胞逐细胞的疾病.
1Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. marubin@umich.edu
Science (New York, N.Y.)
|May 23, 2002
概括
No abstract available in PubMed .
相关概念视频
您也可能阅读
相关文章
通过共同作者、期刊和引用图与本文相关的文章。
排序
Same author
Retraction Note: NSD2 targeting reverses plasticity and drug resistance in prostate cancer.
Nature·2026
Same author
The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics.
Clinical genetics·2026
Same author
A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer.
The Journal of experimental medicine·2026
Same author
The WHO Classification of Genetic Tumour Syndromes: Considerations for histopathology.
Histopathology·2026
Same author
Reversing-or Rewiring-Lineage Plasticity? Lessons from EZH2 Loss in Prostate Cancer.
Cancer research·2026
Same author
A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.
Cancer research·2026
Same journal
Erratum for the Report "Covalently bonded single-molecule junctions with stable and reversible photoswitched conductivity" by C. Jia <i>et al</i>.
Science (New York, N.Y.)·2026


